Welcome to STP
Society of Toxicologic Pathology Vision and four primary goals:
advocacy, education, globalization, and recruitment.
About STP | What Is Toxicologic Pathology? | STP Strategic Plan
2014 Boston Area Pharmaceutical Toxicology Group Spring Meeting— Juvenile Studies: State of the Art and Practice in Safety Assessment to Support Pediatric Drug Development, hosted by Eisai, Inc and Constellation Pharmaceuticals on May 9, 2014
STP Position Paper: Interpreting the Significance of Increased Alveolar Macrophages in Rodents Following Inhalation of Pharmaceutical Materials
Several US FDA guidance documents for electronic regulatory submissions are open for public comments until May 7. The documents are a package for industry that include information on FDASIA, eStudy, a Conformance Guide, and Standards Catalog.
FDA-2014-D-0092—Study Data Technical Conformance Guide and Data Standards Catalog
FDA-2012-D-0097—Guidance on Electronic Submissions: Standardized Study Data
FDA-2014-D-0085—Guidance on Submissions in Electronic Format—Submissions under the Federal Food, Drug, and Cosmetic Act
ACT Webinar Recording: Fundamental Approaches to Immunotoxicity Assessment in Preclinical Safety Studies
(Member login required.)
Survey: Pathology Endpoints in DART/Juvenile Toxicity Studies (Member login required.)
National Capital Region Seminar—April 23, 2014
Toxicology 21 and the 21st Century Toxicologic Pathologist
STP Winter Scope Newsletter is Now Available!
Nonneoplastic Lesion Atlas—The National Toxicology Program (NTP) has created a
New web-based resource containing thousands of high quality images and guidelines for diagnosis of nonneoplastic lesions in experimental rodent models. The first nine sections are now available the NTP website. When completed, the Atlas will contain 56 sections, each focusing on a particular organ or tissue.
Related article in February issue of Toxicologic Pathology.
Pathology for Nonpathologists—This joint ACT/STP course, held every other year, will be held May 12–14 in Rockville, MD.
New CE Course Recordings, Keynote Address Online
Three half-day courses and the keynote from the June 2013 Annual Symposium are now available online for member audio/visual viewing. Inflammatory Biomarkers, Immunogenicity/Hypersensitivity of Biologics, and Environmental Toxicologic Pathology can be accessed on the Web Education section. Gut Microbiota, Low-Grade Inflammation and the Metabolic Syndrome, the keynote address presented by Dr. Andrew Gewirtz, is also available.
Announcing INHAND Nomenclature Change Control
The INHAND Project (International Harmonization of Nomenclature and Diagnostic Criteria for Lesions) is a joint initiative of the STP, ESTP, BSTP and JSTP to develop an internationally-accepted nomenclature for proliferative and non-proliferative lesions in laboratory animals. The INHAND nomenclature is being adopted by the US FDA for use in the SEND initiative (Standard for the Exchange of Nonclinical Data). Pathologists who discover a lesion in a toxicity study that is not covered by the INHAND nomenclature are encouraged to request a new INHAND term. In addition, changes, additions, and updates to current terms may be desirable and may be requested.
Best Practices for Veterinary Toxicologic Clinical Pathology,
with Emphasis on the Pharmaceutical and Biotechnology Industries (DOI: 10.1111/vcp.12059).
Are you unfamiliar with ToxPathNet? STP members can now use a link on the ToxPathNet homepage to view a 3-minute slide show to learn how to navigate this area of the website. (Member login required.)
Navigating the STP Website
A 3-minute slide show is now available to assist in learning to navigate the website. (Select the button on the left to access.)
The Role of the Toxicologic Pathologist in the Biopharmaceutical Industry
As part of an STP initiative to provide awareness of the specialized role of toxicologic pathologists in the biopharmaceutical industry, a review paper was published in the International Journal of Toxicology to educate and to attract new scientists and veterinarians to the field.
*This CE course meets the requirements for 3.5 hours of continuing education as a noninteractive online program, as well as seminar/lecture in jurisdictions which recognize AAVSB’s RACE approval; however participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education. AAVSB RACE Provider #56.